SureTrader Stock Hero Advertisement
Home > Boards > US Listed > Biotechs > Cel-Sci (CVM)

There is a "buyout rumor" circulating right now,

Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Superfly15 Member Profile
 
Followed By 39
Posts 2,745
Boards Moderated 0
Alias Born 03/23/10
160x600 placeholder
Advertisement
Proxy Statement (definitive) (def 14a) "Edgar (US Regulatory)" - 4/21/2015 12:21:56 PM
Amended Annual Report (10-k/a) "Edgar (US Regulatory)" - 4/17/2015 5:18:44 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/13/2015 5:18:47 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/13/2015 5:14:52 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/13/2015 5:11:21 PM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 4/13/2015 5:07:55 PM
UK’s Aintree University Hospital Joins CEL-SCI’s Phase III Head and Neck Cancer Trial "Business Wire" - 4/13/2015 8:38:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 4/2/2015 4:39:45 PM
CEL-SCI Reports 3rd Consecutive Month of Record Patient Enrollment in 2015 for Its Phase III Head and Neck Cancer Trial "Business Wire" - 4/1/2015 8:45:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 3/18/2015 4:31:20 PM
CEL-SCI Reports 2nd Consecutive Month of Record Patient Enrollment in 2015 for Its Phase III Head and Neck Cancer Trial "Business Wire" - 3/3/2015 8:15:00 AM
CEL-SCI Completes Key Milestone with Clearance to Conduct Phase III Trial in 21 Countries "Business Wire" - 2/27/2015 3:22:00 PM
FinancialBuzz.com Exclusive Interview With CEL-SCI CEO Geert Kersten From the Floor of the NYSE "PR Newswire (US)" - 2/23/2015 9:00:00 AM
CEL-SCI To Participate in Ascendiant’s Quarterly Management Discussion Series Today, Friday February 20 at 11 Am Eastern Time "Business Wire" - 2/20/2015 8:00:00 AM
CEL-SCI’s Phase III Head & Neck Cancer Trial Cleared to Begin Patient Enrollment in Malaysia, the 20th Country to Join the ... "Business Wire" - 2/19/2015 8:00:00 AM
Current Report Filing (8-k) "Edgar (US Regulatory)" - 2/18/2015 4:31:40 PM
CEL-SCI to Present at 3rd Annual Sachs Cancer Bio Partnering & Investment Forum "Business Wire" - 2/18/2015 8:00:00 AM
The Philippines is the 19th Country to Clear CEL-SCI for Patient Enrollment in Its Phase III Head and Neck Cancer Trial "Business Wire" - 2/11/2015 8:00:00 AM
CEL-SCI Corporation Reports First Quarter 2015 Financial Results "Business Wire" - 2/6/2015 4:40:00 PM
Quarterly Report (10-q) "Edgar (US Regulatory)" - 2/6/2015 4:16:25 PM
CEL-SCI to Present at 17th Annual BIO CEO & Investor Conference "Business Wire" - 2/5/2015 8:00:00 AM
CEL-SCI Reports Record Monthly Patient Enrollment in Its Phase III Head and Neck Cancer Trial "Business Wire" - 2/2/2015 8:30:00 AM
CEL-SCI Receives Regulatory Clearance to Expand Its Phase III Head and Neck Cancer Trial into Romania "Business Wire" - 1/26/2015 9:00:00 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/9/2015 10:34:25 AM
Statement of Changes in Beneficial Ownership (4) "Edgar (US Regulatory)" - 1/9/2015 10:28:21 AM
Public Reply | Private Reply | Keep | Last ReadPost New MsgReplies (1) | Next 10 | Previous | Next
Follow Board Follow Board Keyboard Shortcuts Report TOS Violation
X
Current Price
Change
Volume
Detailed Quote - Discussion Board
Intraday Chart
+/- to Watchlist